CHAMPIONS ONCOLOGY, INC. Increase (Decrease) in Other Noncurrent Assets
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Increase (Decrease) in Other Noncurrent Assets of -$11.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-09-11
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-07-31 was -$11.00K.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-07-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-04-30 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-01-31 was $0.00, a 100.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent assets for fiscal 2026 was $16.00K.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was $169.00K.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was $0.00.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-07-31 | -$11.00K 10-Q · filed 2026-09-11 | |||
| 2026-04-30 | $16.00K 10-K · filed 2026-07-27 | |||
| 2025-07-31 | $0.00 10-Q · filed 2026-09-11 | $0.00 derived: sum of 2 quarters · filed 2026-09-11 | $0.00 derived: sum of 3 quarters · filed 2026-09-11 | $0.00 derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | $0.00 derived: sum of 2 quarters · filed 2026-07-27 | $0.00 derived: sum of 3 quarters · filed 2026-07-27 | $0.00 10-K · filed 2026-07-27 |
| 2025-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | $0.00 derived: sum of 2 quarters · filed 2025-03-17 | $0.00 10-Q · filed 2025-03-17 | -$1.00K derived: sum of 4 quarters · filed 2025-07-23 |
| 2024-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-16 | $0.00 10-Q · filed 2024-12-16 | -$1.00K derived: sum of 3 quarters · filed 2025-07-23 | $0.00 derived: sum of 4 quarters · filed 2025-07-23 |
| 2024-07-31 | $0.00 10-Q · filed 2024-09-13 | -$1.00K derived: sum of 2 quarters · filed 2025-07-23 | $0.00 derived: sum of 3 quarters · filed 2025-07-23 | $0.00 derived: sum of 4 quarters · filed 2025-07-23 |
| 2024-04-30 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23 | $0.00 derived: sum of 2 quarters · filed 2025-07-23 | $0.00 derived: sum of 3 quarters · filed 2025-07-23 | $169.00K 10-K · filed 2025-07-23 |
| 2024-01-31 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | $1.00K derived: sum of 2 quarters · filed 2025-03-17 | $170.00K 10-Q · filed 2025-03-17 | $170.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-16 | $169.00K 10-Q · filed 2024-12-16 | $169.00K derived: sum of 3 quarters · filed 2024-12-16 | $169.00K derived: sum of 4 quarters · filed 2024-12-16 |
| 2023-07-31 | $169.00K 10-Q · filed 2024-09-13 | $169.00K derived: sum of 2 quarters · filed 2024-09-13 | $169.00K derived: sum of 3 quarters · filed 2024-09-13 | $169.00K derived: sum of 4 quarters · filed 2024-09-13 |
| 2023-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-19 | $0.00 derived: sum of 2 quarters · filed 2024-07-19 | $0.00 derived: sum of 3 quarters · filed 2024-07-19 | $0.00 10-K · filed 2024-07-19 |
| 2023-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-15 | $0.00 derived: sum of 2 quarters · filed 2024-03-15 | $0.00 10-Q · filed 2024-03-15 | |
| 2022-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-13 | $0.00 10-Q · filed 2023-12-13 | ||
| 2022-07-31 | $0.00 10-Q · filed 2023-09-13 | |||
| 2021-07-31 | $70.00K 10-Q · filed 2022-09-12 | |||
| 2020-07-31 | $0.00 10-Q · filed 2021-09-13 | $0.00 derived: sum of 2 quarters · filed 2021-09-13 | ||
| 2020-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28 | $0.00 10-K · filed 2020-07-28 | ||
| 2020-01-31 | $0.00 10-Q · filed 2020-03-16 | |||
| 2019-04-30 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28 | $12.00K 10-K · filed 2020-07-28 | ||
| 2019-01-31 | $21.00K 10-Q · filed 2020-03-16 | |||
| 2018-04-30 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29 | $9.00K 10-K · filed 2019-07-29 | ||
| 2018-01-31 | $0.00 10-Q · filed 2019-03-18 | |||
| 2017-04-30 | $107.00K 10-K · filed 2018-07-30 | |||
| 2016-04-30 | $0.00 10-K · filed 2017-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |